Back to School: How biopharma can reboot drug development. Access exclusive analysis here
Pfenex Inc. (NYSE-M:PFNX) raised $40.5 million through the sale of 2.6 million shares
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury